Literature DB >> 1643653

Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.

R Cherniak1, L C Morris, S A Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1643653     DOI： 10.1016/s0008-6215(00)90505-6

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN： 0008-6215            Impact factor:   2.104


× No keyword cloud information.
  9 in total

1.  Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors.

Authors:  R Blackstock; K L Buchanan; R Cherniak; T G Mitchell; B Wong; A Bartiss; L Jackson; J W Murphy
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy.

Authors:  R Cherniak; E B O'Neill; S Sheng
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Serotyping of Cryptococcus neoformans by dot enzyme assay.

Authors:  T Belay; R Cherniak; E B O'Neill; T R Kozel
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

4.  In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.

Authors:  W Cleare; R Cherniak; A Casadevall
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.

Authors:  T Belay; R Cherniak; T R Kozel; A Casadevall
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.

Authors:  R Cherniak; H Valafar; L C Morris; F Valafar
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

7.  Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay.

Authors:  T Belay; R Cherniak; T Shinoda
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

Review 8.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.

Authors:  T Belay; R Cherniak
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.